Amsterdam-based
SkinVision developed a smartphone app to easily evaluate risk factors for skin cancer and keep track of potentially problematic moles. So far, the app was downloaded in over 1.2 million instances globally, with the most downloads coming from the UK, Australia, the Netherlands, New Zealand, and Germany.
The smart algorithm coupled with dermatologists’ expertise has found over 27,000 cases of skin cancer. The company works closely with Generali in Germany, Central Health Insurance in the Netherlands, providing their entire insured population with the service. These partnerships naturally led to the expansion into Dutch and German versions of the originally English-language app in late 2018.The Medical Futurist asked Matthew Enevoldson, PR Manager at SkinVision about their app, the algorithm behind it and how they see the future of dermatology.